i-Optics presents at prestigious Ophthalmology Innovation Summit in Boston

iopticsThe Hague, April 24, 2014

“Jeroen Cammeraat, CEO at i-Optics, presents Cassini color LED topography device and outstanding clinical results that will help improve patient outcomes in cataract surgery.”

Eye diagnostics innovator i-Optics will present an update on Cassini and compelling clinical data at the Ophthalmology Innovation Summit (OIS) in Boston. This year, CEO Jeroen Cammeraat will focus on Cassini and how this breakthrough technology is expected to impact the way cataract refractive surgery is performed. Cassini is the latest innovation for the true measurement of the cornea for surgery planning and is the first corneal topographer to employ breakthrough color LED topography technology. The color LED measurement principle makes it ideal for more accurate and precise measurement of the cornea. In particular, the true measurement of the axis and magnitude of astigmatism is critical to improve patient outcomes in cataract refractive surgery.

A recent 350 patient study conducted by Professor John A. Kanellopoulos, Clinical Professor of Ophthalmology at New York University School of Medicine, shows that Cassini demonstrated high specificity in measuring corneal astigmatism, with magnitude repeatability under 0.60 Diopters and axial repeatability of less than 3 degrees. This compares to current legacy technologies with astigmatism axis error margins of 15 to 30degrees. With every 3 degree error, one loses 10% of the power of the intraoccular lens implanted as part of the cataract surgery procedure which shows the importance of true axis determination.

Jeroen Cammeraat, CEO i-Optics comments on the breakthrough of Cassini and the opportunity to make a substantial contribution to millions of cataract patients each year saying “With Cassini we can contribute to a paradigm shift in cataract refractive surgery. Today less than 60% of cataract patients have a spectacle-free outcome after surgery. With Cassini we can drive this to a level of 85% or more. This will have a tremendous impact for close to 20 million patients who undergo cataract surgery annually.”

Jeroen Cammeraat will present the data on Thursday April 24 at the OIS meeting in Boston, preceding the annual American Society of Cataract and Refractive Surgery (ASCRS) meeting. Cassini is also presented by i-Optics at the ASCRS meeting taking place this year in Boston, MA from April 25 to April 29.



About i-Optics

i-Optics pioneerssmart and superior eye diagnosis solutions that are affordable, fast and user-friendly for care providers worldwide to serve their patients best. Our innovations include:

  • EasyScan – A breakthrough, zero-dilation retinal imaging system that uses SLO technology to diagnose retinal diseases including diabetic retinopathy, age-related macular degeneration (AMD) and glaucoma.
  • EasyScan three minute eye care test – A full service program for opticians to differentiate their dispensary. The program creates a unique consumer experience that allows the optician to differentiate from competition and boost revenues.
  • EyePrevent –An effective and cost-efficient retinal disease screening service for diabetic and other patients to help prevent vision loss.
  • Cassini – A first-of-its-kind Corneal Shape Analyzer based on Color LED Technology. Cassini measures the true axis and magnitude of corneal astigmatism and is essential for premium IOL planning. Cassini completes the premium cataract-refractive platform.